Bio-Techne Corp. (TECH)
59.63
+0.09
(+0.15%)
USD |
NASDAQ |
Feb 13, 14:13
Bio-Techne Cash from Investing (Quarterly) : -5.921M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp. | -- |
| Align Technology, Inc. | -35.92M |
| LeMaitre Vascular, Inc. | -27.45M |
| Moderna, Inc. | 700.00M |
| CONMED Corp. | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 82.41M |
| Cash from Financing (Quarterly) | -48.99M |
| Free Cash Flow | 223.02M |
| Free Cash Flow Per Share (Quarterly) | 0.4872 |
| Free Cash Flow to Equity (Quarterly) | 120.07M |
| Free Cash Flow to Firm (Quarterly) | 79.18M |
| Free Cash Flow Yield | 2.39% |